O Lohitnavy

Summary

Affiliation: Colorado State University
Country: USA

Publications

  1. ncbi request reprint Reduced oral itraconazole bioavailability by antacid suspension
    M Lohitnavy
    Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand
    J Clin Pharm Ther 30:201-6. 2005
  2. ncbi request reprint Average bioequivalence of clarithromycin immediate released tablet formulations in healthy male volunteers
    M Lohitnavy
    Bioequivalence Test Center, Phitsanulok, Thailand
    Drug Dev Ind Pharm 29:653-9. 2003
  3. ncbi request reprint Average bioequivalence study of clarithromycin tablets in healthy male volunteers
    M Lohitnavy
    Bioequivalence Test Center, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand
    J Clin Pharm Ther 28:187-90. 2003
  4. ncbi request reprint Comparative pharmacokinetics and bioequivalence of two tablet formulations of 2 mg risperidone in healthy Thai male volunteers
    N Khorana
    Bioequivalence Test Center, Department of Pharmaceutical Chemistry and Pharmacognosy, Naresuan University, Phitsanulok, Thailand
    Int J Clin Pharmacol Ther 49:409-14. 2011
  5. ncbi request reprint Pharmacokinetic and bloequivalence studies of generic clarithromycin tablets in healthy male volunteers
    M Lohitnavy
    Bioequivalence Test Center, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand
    Pharmazie 58:72-3. 2003
  6. ncbi request reprint A pharmacokinetic model of the gastrointestinal tract consisting of two segments can describe the concentration-time course of itraconazole
    M Lohitnavy
    Int J Clin Pharmacol Ther 44:394-6. 2006

Collaborators

  • M Lohitnavy
  • N Khorana
  • K Sareekan
  • S Polnok
  • W Chaiyaput
  • A Srichaiya
  • J Sayasathid
  • S Maphanta
  • Y Lu
  • W Srichai
  • O Thangkeattiyanon
  • S Wittaya-areekul
  • P Taytiwat
  • K Chaijittiprasert

Detail Information

Publications6

  1. ncbi request reprint Reduced oral itraconazole bioavailability by antacid suspension
    M Lohitnavy
    Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand
    J Clin Pharm Ther 30:201-6. 2005
    ..To investigate the effects of antacid suspension on oral absorption of itraconazole...
  2. ncbi request reprint Average bioequivalence of clarithromycin immediate released tablet formulations in healthy male volunteers
    M Lohitnavy
    Bioequivalence Test Center, Phitsanulok, Thailand
    Drug Dev Ind Pharm 29:653-9. 2003
    ..17660 +/- 7992, respectively. Relative bioavailability was 0.99. The 90% confidence interval of Cmax and AUC0-infinity were 82.6-112.1% and 84.7-112.0%. Bioequivalence between the Test and Reference formulation can be concluded...
  3. ncbi request reprint Average bioequivalence study of clarithromycin tablets in healthy male volunteers
    M Lohitnavy
    Bioequivalence Test Center, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand
    J Clin Pharm Ther 28:187-90. 2003
    ..To evaluate the average bioequivalence of two formulations of 500 mg clarithromycin tablets in 24 healthy Thai male volunteers...
  4. ncbi request reprint Comparative pharmacokinetics and bioequivalence of two tablet formulations of 2 mg risperidone in healthy Thai male volunteers
    N Khorana
    Bioequivalence Test Center, Department of Pharmaceutical Chemistry and Pharmacognosy, Naresuan University, Phitsanulok, Thailand
    Int J Clin Pharmacol Ther 49:409-14. 2011
    ..Risperidone is primarily converted by the cytochrome P450 2D6 (CYP2D6) and 3A4 (CYP3A4) enzymes to 9-hydroxyrisperidone, its active metabolite with equivalent potency to the parent compound...
  5. ncbi request reprint Pharmacokinetic and bloequivalence studies of generic clarithromycin tablets in healthy male volunteers
    M Lohitnavy
    Bioequivalence Test Center, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand
    Pharmazie 58:72-3. 2003
  6. ncbi request reprint A pharmacokinetic model of the gastrointestinal tract consisting of two segments can describe the concentration-time course of itraconazole
    M Lohitnavy
    Int J Clin Pharmacol Ther 44:394-6. 2006